Aquestive Therapeutics, Inc. (AQST) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.81M | -8.47M | -12.65M | -7.91M | -23.4M | -6.49M | -11.88M | -7.01M | -10.38M | -4.94M | -2.35M | -7.91M |
| Operating CF Margin % | -102.49% | -65.07% | -98.77% | -79.12% | -268.35% | -54.68% | -87.73% | -34.86% | -86.15% | -37.42% | -18.05% | -59.72% |
| Operating CF Growth % | 36.73% | -30.51% | -6.47% | -12.96% | -125.35% | -31.3% | -406.18% | 11.39% | -217.79% | -158.51% | -183.55% | -20.5% |
| Net Income | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M |
| Depreciation & Amortization | 119K | 130K | 139K | 140K | 139K | 147K | 159K | 205K | 207K | 467K | 263K | 289K |
| Stock-Based Compensation | 0 | 1.38M | 2.78M | 1.88M | 1.59M | 2.4M | 1.58M | 1.54M | 1.58M | 940K | 774K | 631K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.53M | 0 | 0 |
| Other Non-Cash Items | 5.52M | 2.75M | 2.76M | 2.69M | 2.8M | 2.73M | 2.73M | 2.36M | 2.71M | 5.39M | 88K | 52K |
| Working Capital Changes | -12.39M | 19.14M | -2.88M | 919K | -4.99M | 5.28M | -4.83M | -8.36M | -2.05M | -1.1M | -1.44M | -3.09M |
| Change in Receivables | 10.9M | -5.96M | 63K | -1.35M | -3.13M | 2.32M | -2.49M | 2.34M | 147K | 104K | 2.13M | -2.51M |
| Change in Inventory | -1.9M | 1.71M | 241K | -927K | -1.15M | 977K | -55K | 768K | -965K | 310K | -1.13M | 1.03M |
| Change in Payables | -17.97M | 19.25M | -1.31M | -323K | 1.91M | 2.64M | 1.88M | -3.01M | 1.28M | -1.07M | -695K | -1.75M |
| Cash from Investing | -52K | -85K | -235K | -107K | -135K | -15K | -80K | -35K | -29K | -16K | -151K | -826K |
| Capital Expenditures | -52K | -85K | -235K | -107K | -135K | -15K | -80K | -35K | -29K | -16K | -151K | -826K |
| CapEx % of Revenue | 0.36% | 0.65% | 1.83% | 1.07% | 1.55% | 0.13% | 0.59% | 0.17% | 0.24% | 0.12% | 1.16% | 6.24% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.42M | 660K | 81.41M | -100K | 20.65M | 157K | -17K | 1.71M | 81.74M | 3.91M | 4.98M | 4.29M |
| Debt Issued (Net) | -8K | -5K | -7K | -8K | -11K | -5K | -8K | -5K | -5K | -38.98M | 1.02M | -4.48M |
| Equity Issued (Net) | 4.76M | 683K | 79.72M | -124K | 21.36M | -34K | 193K | 1.69M | 82.1M | 3.64M | 184K | 4.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -329K | -18K | 1.7M | 32K | -703K | 196K | -202K | 25K | -354K | 39.26M | 3.77M | 4.6M |
| Net Change in Cash | -10.44M | -7.89M | 68.53M | -8.12M | -2.89M | -6.35M | -11.98M | -5.33M | 71.33M | -1.04M | 2.48M | -4.45M |
| Free Cash Flow | -14.86M | -8.55M | -12.88M | -8.02M | -23.54M | -6.5M | -11.96M | -7.04M | -10.41M | -4.96M | -2.5M | -8.73M |
| FCF Margin % | -102.85% | -65.72% | -100.6% | -80.19% | -269.9% | -54.81% | -88.32% | -35.03% | -86.39% | -37.54% | -19.21% | -65.95% |
| FCF Growth % | 36.87% | -31.52% | -7.73% | -13.92% | -126.02% | -31.18% | -378.78% | 19.37% | -218.14% | -158.88% | -328.75% | -20.64% |
| FCF per Share | -0.12 | -0.07 | -0.12 | -0.08 | -0.25 | -0.07 | -0.13 | -0.08 | -0.14 | -0.07 | -0.04 | -0.15 |
| FCF Conversion (FCF/Net Income) | 1.84x | 0.27x | 0.82x | 0.58x | 1.02x | 0.38x | 1.03x | 2.55x | 0.81x | 0.61x | 1.15x | 1.37x |
| Interest Paid | 0 | 0 | 1.52M | 1.52M | 0 | 1.53M | 0 | 0 | 0 | 0 | 0 | 1.35M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |